ID   NAGAB_HUMAN             Reviewed;         411 AA.
AC   P17050;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 2.
DT   10-MAY-2017, entry version 183.
DE   RecName: Full=Alpha-N-acetylgalactosaminidase;
DE            EC=3.2.1.49;
DE   AltName: Full=Alpha-galactosidase B;
DE   Flags: Precursor;
GN   Name=NAGA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Lung;
RX   PubMed=2174888;
RA   Wang A.M., Bishop D.F., Desnick R.J.;
RT   "Human alpha-N-acetylgalactosaminidase-molecular cloning, nucleotide
RT   sequence, and expression of a full-length cDNA. Homology with human
RT   alpha-galactosidase A suggests evolution from a common ancestral
RT   gene.";
RL   J. Biol. Chem. 265:21859-21866(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1646157; DOI=10.1016/0888-7543(91)90493-X;
RA   Wang A.M., Desnick R.J.;
RT   "Structural organization and complete sequence of the human alpha-N-
RT   acetylgalactosaminidase gene: homology with the alpha-galactosidase A
RT   gene provides evidence for evolution from a common ancestral gene.";
RL   Genomics 10:133-142(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=2551294; DOI=10.1016/0006-291X(89)91149-2;
RA   Tsuji S., Yamauchi T., Hiraiwa M., Isobe T., Okuyama T., Sakimura K.,
RA   Takahashi Y., Nishizawa M., Uda Y., Miyatake T.;
RT   "Molecular cloning of a full-length cDNA for human alpha-N-
RT   acetylgalactosaminidase (alpha-galactosidase B).";
RL   Biochem. Biophys. Res. Commun. 163:1498-1504(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2372288; DOI=10.1016/0006-291X(90)91264-S;
RA   Yamauchi T., Hiraiwa M., Kobayashi H., Uda Y., Miyatake T., Tsuji S.;
RT   "Molecular cloning of two species of cDNAs for human alpha-N-
RT   acetylgalactosaminidase and expression in mammalian cells.";
RL   Biochem. Biophys. Res. Commun. 170:231-237(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 18-37.
RC   TISSUE=Placenta;
RX   PubMed=2256909; DOI=10.1016/S0006-291X(05)81014-9;
RA   Warner T.G., Louie A., Potier M.;
RT   "Photolabeling of the alpha-neuraminidase/beta-galactosidase complex
RT   from human placenta with a photoreactive neuraminidase inhibitor.";
RL   Biochem. Biophys. Res. Commun. 173:13-19(1990).
RN   [9]
RP   FUNCTION.
RX   PubMed=9741689;
RA   Asfaw B., Schindler D., Ledvinova J., Cerny B., Smid F.,
RA   Conzelmann E.;
RT   "Degradation of blood group A glycolipid A-6-2 by normal and mutant
RT   human skin fibroblasts.";
RL   J. Lipid Res. 39:1768-1780(1998).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-322 AND SER-332, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.M700120-MCP200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,
RA   Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate
RT   reductase M2 subunit phosphorylation at residue serine 20 in canonical
RT   Wnt signal transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-177 AND ASN-201.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 18-411 IN COMPLEXES WITH
RP   N-ACETYLGALACTOSAMINE AND GALACTOSE, DISULFIDE BONDS, GLYCOSYLATION AT
RP   ASN-124; ASN-177 AND ASN-385, SUBUNIT, CATALYTIC ACTIVITY, AND
RP   MUTAGENESIS OF ASN-201.
RX   PubMed=19683538; DOI=10.1016/j.jmb.2009.08.021;
RA   Clark N.E., Garman S.C.;
RT   "The 1.9 A structure of human alpha-N-acetylgalactosaminidase: the
RT   molecular basis of Schindler and Kanzaki diseases.";
RL   J. Mol. Biol. 393:435-447(2009).
RN   [14]
RP   VARIANT SCHIND LYS-325.
RX   PubMed=2243144; DOI=10.1172/JCI114901;
RA   Wang A.M., Schindler D., Desnick R.J.;
RT   "Schindler disease: the molecular lesion in the alpha-N-
RT   acetylgalactosaminidase gene that causes an infantile neuroaxonal
RT   dystrophy.";
RL   J. Clin. Invest. 86:1752-1756(1990).
RN   [15]
RP   VARIANT KANZD TRP-329, AND CHARACTERIZATION OF VARIANT KANZD TRP-329.
RX   PubMed=8040340; DOI=10.1172/JCI117404;
RA   Wang A.M., Kanzaki T., Desnick R.J.;
RT   "The molecular lesion in the alpha-N-acetylgalactosaminidase gene that
RT   causes angiokeratoma corporis diffusum with glycopeptiduria.";
RL   J. Clin. Invest. 94:839-845(1994).
RN   [16]
RP   VARIANTS SCHIND CYS-160 AND LYS-325.
RX   PubMed=8782044; DOI=10.1136/jmg.33.6.458;
RA   Keulemans J.L.M., Reuser A.J.J., Kroos M.A., Willemsen R.,
RA   Hermans M.M.P., van den Ouweland A.M.W., de Jong J.G.N., Wevers R.A.,
RA   Renier W.O., Schindler D., Coll M.J., Chabas A., Sakuraba H.,
RA   Suzuki Y., van Diggelen O.P.;
RT   "Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new
RT   mutations and the paradox between genotype and phenotype.";
RL   J. Med. Genet. 33:458-464(1996).
RN   [17]
RP   VARIANT KANZD GLN-329.
RX   PubMed=11251574; DOI=10.1046/j.1365-2133.2001.04028.x;
RA   Kodama K., Kobayashi H., Abe R., Ohkawara A., Yoshii N., Yotsumoto S.,
RA   Fukushige T., Nagatsuka Y., Hirabayashi Y., Kanzaki T.;
RT   "A new case of alpha-N-acetylgalactosaminidase deficiency with
RT   angiokeratoma corporis diffusum, with Meniere's syndrome and without
RT   mental retardation.";
RL   Br. J. Dermatol. 144:363-368(2001).
CC   -!- FUNCTION: Removes terminal alpha-N-acetylgalactosamine residues
CC       from glycolipids and glycopeptides. Required for the breakdown of
CC       glycolipids. {ECO:0000269|PubMed:9741689}.
CC   -!- CATALYTIC ACTIVITY: Cleavage of non-reducing alpha-(1->3)-N-
CC       acetylgalactosamine residues from human blood group A and AB mucin
CC       glycoproteins, Forssman hapten and blood group A lacto series
CC       glycolipids. {ECO:0000269|PubMed:19683538}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:19683538}.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- DISEASE: Schindler disease (SCHIND) [MIM:609241]: Form of NAGA
CC       deficiency characterized by early-onset neuroaxonal dystrophy and
CC       neurological signs (convulsion during fever, epilepsy, psychomotor
CC       retardation and hypotonia). NAGA deficiency is typically
CC       classified in three main phenotypes: NAGA deficiency type I
CC       (Schindler disease or Schindler disease type I) with severe
CC       manifestations; NAGA deficiency type II (Kanzazi disease or
CC       Schindler disease type II) which is mild; NAGA deficiency type III
CC       (Schindler disease type III) characterized by mild-to-moderate
CC       neurologic manifestations. NAGA deficiency results in the
CC       increased urinary excretion of glycopeptides and oligosaccharides
CC       containing alpha-N-acetylgalactosaminyl moieties. Inheritance is
CC       autosomal recessive. {ECO:0000269|PubMed:2243144,
CC       ECO:0000269|PubMed:8782044}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Kanzaki disease (KANZD) [MIM:609242]: Autosomal recessive
CC       disorder characterized by late-onset, angiokeratoma corporis
CC       diffusum and mild intellectual impairment.
CC       {ECO:0000269|PubMed:11251574, ECO:0000269|PubMed:8040340}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Alpha-galactosidase B was first found to be an
CC       isoenzyme of alpha-galactosidases, but apparently it differs from
CC       alpha-galactosidase A in substrate specificity and is alpha-N-
CC       acetylgalactosaminidase.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 27 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA59902.1; Type=Frameshift; Positions=320; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M62783; AAA51677.1; -; mRNA.
DR   EMBL; M59199; AAB06718.1; -; Genomic_DNA.
DR   EMBL; M29276; AAA59902.1; ALT_FRAME; mRNA.
DR   EMBL; M38083; AAA36351.1; -; mRNA.
DR   EMBL; CR456527; CAG30413.1; -; mRNA.
DR   EMBL; Z99716; CAB41237.1; -; Genomic_DNA.
DR   EMBL; BC000095; AAH00095.1; -; mRNA.
DR   CCDS; CCDS14030.1; -.
DR   PIR; A33265; A33265.
DR   PIR; A36530; A35485.
DR   RefSeq; NP_000253.1; NM_000262.2.
DR   RefSeq; XP_005261672.1; XM_005261615.4.
DR   RefSeq; XP_005261673.1; XM_005261616.4.
DR   UniGene; Hs.75372; -.
DR   PDB; 3H53; X-ray; 2.01 A; A/B=18-411.
DR   PDB; 3H54; X-ray; 2.20 A; A/B=18-411.
DR   PDB; 3H55; X-ray; 1.91 A; A/B=18-411.
DR   PDB; 3IGU; X-ray; 2.15 A; A/B=18-411.
DR   PDB; 4DO4; X-ray; 1.40 A; A/B=18-411.
DR   PDB; 4DO5; X-ray; 1.51 A; A/B=18-411.
DR   PDB; 4DO6; X-ray; 1.60 A; A/B=18-411.
DR   PDBsum; 3H53; -.
DR   PDBsum; 3H54; -.
DR   PDBsum; 3H55; -.
DR   PDBsum; 3IGU; -.
DR   PDBsum; 4DO4; -.
DR   PDBsum; 4DO5; -.
DR   PDBsum; 4DO6; -.
DR   ProteinModelPortal; P17050; -.
DR   SMR; P17050; -.
DR   BioGrid; 110749; 5.
DR   STRING; 9606.ENSP00000379680; -.
DR   ChEMBL; CHEMBL3132; -.
DR   DrugBank; DB04077; Glycerol.
DR   SwissLipids; SLP:000001402; -.
DR   CAZy; GH27; Glycoside Hydrolase Family 27.
DR   iPTMnet; P17050; -.
DR   PhosphoSitePlus; P17050; -.
DR   UniCarbKB; P17050; -.
DR   BioMuta; NAGA; -.
DR   DMDM; 127801; -.
DR   EPD; P17050; -.
DR   MaxQB; P17050; -.
DR   PaxDb; P17050; -.
DR   PeptideAtlas; P17050; -.
DR   PRIDE; P17050; -.
DR   DNASU; 4668; -.
DR   Ensembl; ENST00000396398; ENSP00000379680; ENSG00000198951.
DR   Ensembl; ENST00000402937; ENSP00000384603; ENSG00000198951.
DR   Ensembl; ENST00000403363; ENSP00000385283; ENSG00000198951.
DR   GeneID; 4668; -.
DR   KEGG; hsa:4668; -.
DR   UCSC; uc003bbw.5; human.
DR   CTD; 4668; -.
DR   DisGeNET; 4668; -.
DR   GeneCards; NAGA; -.
DR   HGNC; HGNC:7631; NAGA.
DR   HPA; HPA000649; -.
DR   MalaCards; NAGA; -.
DR   MIM; 104170; gene.
DR   MIM; 609241; phenotype.
DR   MIM; 609242; phenotype.
DR   neXtProt; NX_P17050; -.
DR   OpenTargets; ENSG00000198951; -.
DR   Orphanet; 79279; Alpha-N-acetylgalactosaminidase deficiency type 1.
DR   Orphanet; 79280; Alpha-N-acetylgalactosaminidase deficiency type 2.
DR   Orphanet; 79281; Alpha-N-acetylgalactosaminidase deficiency type 3.
DR   PharmGKB; PA31435; -.
DR   eggNOG; KOG2366; Eukaryota.
DR   eggNOG; ENOG410XPF1; LUCA.
DR   GeneTree; ENSGT00390000008751; -.
DR   HOGENOM; HOG000161224; -.
DR   HOVERGEN; HBG001989; -.
DR   InParanoid; P17050; -.
DR   KO; K01204; -.
DR   OMA; FVEHQDI; -.
DR   OrthoDB; EOG091G0BGV; -.
DR   PhylomeDB; P17050; -.
DR   TreeFam; TF312909; -.
DR   BioCyc; MetaCyc:HS01993-MONOMER; -.
DR   BRENDA; 3.2.1.49; 2681.
DR   SABIO-RK; P17050; -.
DR   EvolutionaryTrace; P17050; -.
DR   GeneWiki; NAGA_(gene); -.
DR   GenomeRNAi; 4668; -.
DR   PRO; PR:P17050; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000198951; -.
DR   CleanEx; HS_NAGA; -.
DR   ExpressionAtlas; P17050; baseline and differential.
DR   Genevisible; P17050; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0004557; F:alpha-galactosidase activity; IBA:GO_Central.
DR   GO; GO:0008456; F:alpha-N-acetylgalactosaminidase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0016052; P:carbohydrate catabolic process; IDA:UniProtKB.
DR   GO; GO:0019377; P:glycolipid catabolic process; IMP:UniProtKB.
DR   GO; GO:0016139; P:glycoside catabolic process; IBA:GO_Central.
DR   CDD; cd14792; GH27; 1.
DR   Gene3D; 3.20.20.70; -; 2.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR002241; Glyco_hydro_27.
DR   InterPro; IPR000111; Glyco_hydro_27/36_CS.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   Pfam; PF16499; Melibiase_2; 1.
DR   PRINTS; PR00740; GLHYDRLASE27.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   PROSITE; PS00512; ALPHA_GALACTOSIDASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Epilepsy; Glycoprotein; Glycosidase;
KW   Hydrolase; Lysosome; Phosphoprotein; Reference proteome; Signal.
FT   SIGNAL        1     17       {ECO:0000269|PubMed:2256909}.
FT   CHAIN        18    411       Alpha-N-acetylgalactosaminidase.
FT                                /FTId=PRO_0000001018.
FT   REGION       78     79       Substrate binding.
FT   ACT_SITE    156    156       Nucleophile.
FT   ACT_SITE    217    217       Proton donor.
FT   BINDING     154    154       Substrate.
FT   BINDING     188    188       Substrate.
FT   BINDING     213    213       Substrate.
FT   BINDING     217    217       Substrate.
FT   MOD_RES     322    322       Phosphoserine.
FT                                {ECO:0000244|PubMed:17693683}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000244|PubMed:17693683}.
FT   CARBOHYD    124    124       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19683538}.
FT   CARBOHYD    177    177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19683538}.
FT   CARBOHYD    201    201       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    359    359       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    385    385       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19683538}.
FT   DISULFID     38     80       {ECO:0000269|PubMed:19683538}.
FT   DISULFID     42     49       {ECO:0000269|PubMed:19683538}.
FT   DISULFID    127    158       {ECO:0000269|PubMed:19683538}.
FT   DISULFID    187    209       {ECO:0000269|PubMed:19683538}.
FT   VARIANT     160    160       S -> C (in SCHIND; type III;
FT                                dbSNP:rs121434532).
FT                                {ECO:0000269|PubMed:8782044}.
FT                                /FTId=VAR_000496.
FT   VARIANT     325    325       E -> K (in SCHIND; type I and type III;
FT                                dbSNP:rs121434529).
FT                                {ECO:0000269|PubMed:2243144,
FT                                ECO:0000269|PubMed:8782044}.
FT                                /FTId=VAR_000497.
FT   VARIANT     329    329       R -> Q (in KANZD; dbSNP:rs121434533).
FT                                {ECO:0000269|PubMed:11251574}.
FT                                /FTId=VAR_022525.
FT   VARIANT     329    329       R -> W (in KANZD; loss of activity;
FT                                dbSNP:rs121434530).
FT                                {ECO:0000269|PubMed:8040340}.
FT                                /FTId=VAR_000498.
FT   MUTAGEN     201    201       N->Q: Loss of glycosylation site; no
FT                                effect on enzyme activity and stability.
FT                                {ECO:0000269|PubMed:19683538}.
FT   CONFLICT     24     24       Q -> N (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    165    165       R -> A (in Ref. 2; AAA59902).
FT                                {ECO:0000305}.
FT   CONFLICT    175    175       A -> G (in Ref. 2; AAA59902).
FT                                {ECO:0000305}.
FT   CONFLICT    205    205       L -> Q (in Ref. 2; AAA59902).
FT                                {ECO:0000305}.
FT   STRAND       28     32       {ECO:0000244|PDB:4DO4}.
FT   HELIX        33     36       {ECO:0000244|PDB:4DO4}.
FT   TURN         42     44       {ECO:0000244|PDB:4DO4}.
FT   TURN         46     48       {ECO:0000244|PDB:4DO4}.
FT   STRAND       49     51       {ECO:0000244|PDB:4DO4}.
FT   HELIX        52     64       {ECO:0000244|PDB:4DO4}.
FT   HELIX        67     70       {ECO:0000244|PDB:4DO4}.
FT   STRAND       74     76       {ECO:0000244|PDB:4DO4}.
FT   STRAND       82     85       {ECO:0000244|PDB:4DO4}.
FT   STRAND       91     93       {ECO:0000244|PDB:4DO4}.
FT   TURN         95     97       {ECO:0000244|PDB:4DO4}.
FT   HELIX       102    111       {ECO:0000244|PDB:4DO4}.
FT   STRAND      115    125       {ECO:0000244|PDB:4DO4}.
FT   HELIX       135    137       {ECO:0000244|PDB:4DO4}.
FT   HELIX       138    147       {ECO:0000244|PDB:4DO4}.
FT   STRAND      152    156       {ECO:0000244|PDB:4DO4}.
FT   HELIX       162    178       {ECO:0000244|PDB:4DO4}.
FT   STRAND      184    187       {ECO:0000244|PDB:4DO4}.
FT   HELIX       189    192       {ECO:0000244|PDB:4DO4}.
FT   TURN        197    199       {ECO:0000244|PDB:4DO4}.
FT   HELIX       202    208       {ECO:0000244|PDB:4DO4}.
FT   STRAND      210    213       {ECO:0000244|PDB:4DO4}.
FT   HELIX       222    234       {ECO:0000244|PDB:4DO4}.
FT   HELIX       236    239       {ECO:0000244|PDB:4DO4}.
FT   HELIX       240    242       {ECO:0000244|PDB:4DO4}.
FT   STRAND      247    250       {ECO:0000244|PDB:4DO4}.
FT   STRAND      258    260       {ECO:0000244|PDB:4DO4}.
FT   HELIX       263    275       {ECO:0000244|PDB:4DO4}.
FT   STRAND      280    282       {ECO:0000244|PDB:4DO4}.
FT   TURN        286    288       {ECO:0000244|PDB:4DO4}.
FT   HELIX       291    297       {ECO:0000244|PDB:4DO4}.
FT   HELIX       300    306       {ECO:0000244|PDB:4DO4}.
FT   STRAND      315    319       {ECO:0000244|PDB:4DO4}.
FT   STRAND      323    330       {ECO:0000244|PDB:4DO4}.
FT   HELIX       332    334       {ECO:0000244|PDB:4DO4}.
FT   STRAND      336    342       {ECO:0000244|PDB:4DO4}.
FT   STRAND      345    347       {ECO:0000244|PDB:4DO4}.
FT   STRAND      349    354       {ECO:0000244|PDB:4DO4}.
FT   HELIX       355    358       {ECO:0000244|PDB:4DO4}.
FT   STRAND      365    370       {ECO:0000244|PDB:4DO4}.
FT   TURN        371    373       {ECO:0000244|PDB:4DO4}.
FT   STRAND      376    380       {ECO:0000244|PDB:4DO4}.
FT   STRAND      385    390       {ECO:0000244|PDB:4DO4}.
FT   STRAND      395    403       {ECO:0000244|PDB:4DO4}.
FT   HELIX       405    408       {ECO:0000244|PDB:4DO4}.
SQ   SEQUENCE   411 AA;  46565 MW;  781A0728C0B29CD9 CRC64;
     MLLKTVLLLG HVAQVLMLDN GLLQTPPMGW LAWERFRCNI NCDEDPKNCI SEQLFMEMAD
     RMAQDGWRDM GYTYLNIDDC WIGGRDASGR LMPDPKRFPH GIPFLADYVH SLGLKLGIYA
     DMGNFTCMGY PGTTLDKVVQ DAQTFAEWKV DMLKLDGCFS TPEERAQGYP KMAAALNATG
     RPIAFSCSWP AYEGGLPPRV NYSLLADICN LWRNYDDIQD SWWSVLSILN WFVEHQDILQ
     PVAGPGHWND PDMLLIGNFG LSLEQSRAQM ALWTVLAAPL LMSTDLRTIS AQNMDILQNP
     LMIKINQDPL GIQGRRIHKE KSLIEVYMRP LSNKASALVF FSCRTDMPYR YHSSLGQLNF
     TGSVIYEAQD VYSGDIISGL RDETNFTVII NPSGVVMWYL YPIKNLEMSQ Q
//
